BioWorld

May 21, 2012

View Archived Issues

BioWorld Stock Report For Public Biotechnology Companies

Stock Gainers and Losers For The Week

Money Raised by Biotech Jan. 1 - May 18, 2012

Money Raised by Biotech 2012 Vs. 2011

Biotech-Biotech Collaborations: Modified And Terminated Agreements: April 1 - May 18, 2012

Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: April 1 - May 18, 2012

Biotechnology Company Deals With Other Biotechnology Companies: April 1 - May 18, 2012

Top Deals Between Biotech Companies: 2012

Investment Practice Changes By LPs Could Help Startups

The Ewing Marion Kauffman Foundation issued a report this month blaming the lackluster returns from venture capital on a lack of oversight from limited partners (LPs) that invest in the funds. Read More

Novartis Expands R&D as Other Pharmas Cut Back

At a time when many big pharmas are trimming internal research programs, Novartis AG has been quietly expanding. Read More

Week in Review

Word on the Street

Week in Washington

Today's news in brief

BioWorld

BioWorld briefs for June 4, 2026.

ASCO 2026: A revolution in pancreatic cancer

BioWorld

At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 2, 2026

EASL 2026: Emerging liver disease targets to watch

BioWorld

At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...

Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

BioWorld

Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...